Rick Simpson Oil in Russell County, Alabama: The Complete Guide by OilWell Cannabis

If you’re reading this from Russell County — maybe in Phenix City after a long day, maybe out in Hurtsboro or Seale, maybe caring for someone at Russell Medical Center — you already know the feeling. The moment when the doctor says, “We’ve tried everything,” or the prescription bottle says “take as needed,” but needed never seems to come. Or maybe you’re one of the thousands of veterans living near Fort Benning who’ve discovered that what works for the body doesn’t always work for the mind. You’re looking for something real, something honest, something that doesn’t require a medical card you can’t get or a trip to Birmingham you can’t afford.

We wrote this for you. Not for search engines. Not for hype. For the cancer patient in Phenix City trying to understand what’s in that “RSO” someone mentioned. For the veteran in Ladonia dealing with PTSD when the pills stop working. For the caregiver in Fort Mitchell watching someone you love disappear into dementia or arthritis pain. For everyone in Russell County who’s been failed by conventional medicine and is looking for straight answers about cannabis oil.

We’re OilWell Cannabis, based in Houston, Texas. We’ve spent the last decade building something different: a legal, lab-tested, multi-cannabinoid Rick Simpson Oil that respects the origin story while fixing every problem that made the original dangerous. And we’re publishing our complete formula — every milligram, every percentage — so you can decide whether to buy from us or make your own. That’s our promise: no snake oil, no false hope, just the best possible version of the information so you can give it a fair shot and decide what’s right for you.

This is going to be thorough, because you deserve thorough. We’ll cover Rick Simpson’s actual history (not the internet myth), what traditional RSO really was, why most products labeled “RSO” today aren’t it, what seven years of media scrutiny taught us, and exactly what’s in our formula — with every claim tied to peer-reviewed research. We’ll talk about Alabama law, Russell County access, and how to use these products safely whether you’re dealing with cancer, chronic pain, sleep issues, or PTSD. And we’ll do it in plain English, first-person plural, like we’re sitting on your porch in Russell County having this conversation face-to-face.

No shortcuts. No fluff. Just everything we know, everything we’ve learned from keeping Bentley alive for ten years, everything we’ve validated through ABC13’s cameras, and everything the science actually says. Let’s begin.

Who Was Rick Simpson, and What Did He Actually Create?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor. He wasn’t a scientist. He was a power engineer and maintenance worker — a blue-collar tradesman from a place not unlike parts of Russell County where people work with their hands and trust what they can see and touch. His path into cannabis started the same way most people’s does: the medical system failed him completely.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. For Russell County folks who’ve worked construction, manufacturing, or any physical trade, this story hits home. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications either didn’t help or made things worse. Sound familiar? We hear this from people in Phenix City, from veterans around Fort Benning, from folks in every corner of Alabama who’ve been told there’s a pill for everything until the pills stop working.

Simpson discovered cannabis provided more relief than anything his doctors offered. But when he asked his physician to support or prescribe it, the request was refused . That refusal — that institutional dismissal of something that was actually helping — is what set everything else in motion.

The 1974 Study and the Skin Cancer Incident

Simpson’s interest deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study was originally intended to demonstrate harm. Its findings were never replicated in controlled human cancer trials , but it became Simpson’s scientific anchor.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days .

Important context: No independent medical verification of this outcome has ever been published. No biopsy confirmation. No clinical follow-up in any peer-reviewed source. This is personal testimony, not medical evidence. But it is historically significant as the catalyst for a global movement.

For Russell County residents facing cancer diagnoses at Russell Medical Center or traveling to East Alabama Health in Opelika, we know this story resonates. When you’re desperate, you’ll listen to anyone who says they’ve found a way. Our job is to honor that desperation with honesty, not hype.

The Crusade: Giving It Away for Free

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free — no charge, no profit, no gatekeeping. By his account, he helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .

He reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film became foundational in cannabis communities worldwide — for many, it was their first introduction to concentrated cannabis oil as medicine .

But his advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He faced charges for cultivation, possession, and trafficking. Eventually, he left Canada for Europe, living in Croatia and the Netherlands while continuing his advocacy .

In 2012, he published Phoenix Tears: The Rick Simpson Story, documenting his experience and oil-making process . Throughout his public career, Simpson maintained that cannabis oil could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as a fight against institutional corruption .

What Simpson was not: He was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, or clinical research. He never designed, conducted, or published a clinical trial. His evidence base was personal experience and testimonials, gathered informally without controls, independent verification, or long-term follow-up.

What he got right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: His cure claims exceeded the evidence. Encouraging patients to rely on RSO in place of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern.

Traditional RSO vs. Modern Formulated RSO: What Russell County Needs to Know

If you’re in Russell County and you’ve seen “RSO” at a shop in Columbus or online, you need to understand: most products labeled RSO today bear little resemblance to what Simpson made. The term has become generic. Here’s what actually changed:

The Solvent Problem: Why Traditional RSO Was Dangerous

Traditional RSO used naphtha — petroleum-based lighter fluid — or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging is difficult to verify without lab testing.

Modern extraction uses food-grade ethanol or supercritical CO₂. This is one of the most straightforward improvements the regulated industry made over the traditional model. Our products are solvent-free blends of individual cannabinoid distillates combined in controlled production environments. No naphtha. No isopropyl. No risk.

Why We Preserve THCa: The Decarboxylation Choice

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa to delta-9 THC, leaving no choice about psychoactivity.

Our sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. This creates three usage options:

Option 1: Raw, No Heat — All 1,500 mg stays as THCa, completely non-psychoactive. Research suggests potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is compatible with work, driving, and daytime use with zero impairment.

Option 2: Fully Activated at Home — Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC. Combined with 6,000 mg delta-8 THC, this achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because activation happens after purchase under your control.

Option 3: Vape Cartridge — Vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest onset (1-2 minutes) for acute situations.

The conversion: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation [12].

For Russell County residents who work at the restaurants serving Fort Benning, who drive trucks, who operate machinery at local manufacturing plants, who need to be present for their families — this choice matters. You decide whether to use it raw for non-psychoactive benefits or decarboxylated for full potency. That’s patient control.

The OilWell Story: From a Dying Dog to Russell County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story starts long before Houston — it starts in McAllen, Texas, right across the river from Reynosa, Mexico, in the Borderplex region. If you think parts of Russell County have seen economic hardship, McAllen-Reynosa is another level: poverty, cartel violence, systemic challenges. Colin learned to hustle early, taking on risky work transporting items across the border. Many of his best friends have been killed or are in prison because of those dangers. He left home at sixteen.

Despite that environment, Colin didn’t fall into the darkest paths. He focused on cannabis, seeing it as safer and more beneficial than harder substances. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows, then transitioned to legal business.

He later became a formally trained software engineer and did custom development for Baylor College of Medicine in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines our approach today.

Bentley: The Dog Who Started Everything

The company began with a dog named Bentley. Bentley was more than a pet — he was family. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy.

Giving up wasn’t an option. Colin had already faced too much loss. In a desperate search for alternatives, a rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question exposed a blind spot that would become a mission.

Colin learned to create CBD golden paste. It wasn’t a cure, but it was a lifeline. And that lifeline delivered what veterinary medicine said was impossible: Bentley got up, walked over to Colin, and brought him his ball to play. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure. Crippling arthritis led him to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork. That decade of real-world formulation testing on a patient Colin loved more than anything is why our RSO has seven cannabinoids instead of one or two.

Colin’s Personal Battle: PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — a feat notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive. Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not. That lived experience is why veterans across the country — including those around Fort Benning in Russell County’s backyard — connect with our products.

Our ABC13 Media Record: Seven Features, Four Years, One Voice

Between September 2019 and April 2023, ABC13 Houston featured us in seven distinct news segments. Five different reporters across four years sought us out for CBD business, Delta-8 legal analysis, COVID community health leadership, criminal justice reform, and cannabis business pioneering.

Why this matters for Russell County: That kind of mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When you’re deciding whether to trust a company with your health, knowing they’ve been vetted by independent journalists — not just marketers — matters.

September 15, 2019 — Our first feature, where Colin laid out our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” That quote is still our north star.

March 22, 2021 — We helped another entrepreneur, Jonathan Pina, launch a direct-to-consumer business. Colin’s quote: “Pain comes in a lot of different forms.” We see this daily in Russell County — veterans with PTSD, cancer patients, chronic pain sufferers, caregivers burning out.

May 24, 2021 — Steve Campion’s Delta-8 investigation. When asked why someone would want to smoke it, Colin’s unfiltered response: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* That radical honesty on mainstream TV — preserved by the network — is who we are.

August 20, 2021 — Our biggest community action: We gave away 1,000 caviar pre-rolls (worth ~$35,000) to encourage COVID vaccination. We coordinated with the city of Houston. No political strings. Just: “We want Houston to be as healthy as possible.” That same impulse drives us to serve Russell County now.

October 19, 2021 — When Texas DSHS classified Delta-8 as Schedule I overnight, we proactively removed all products before enforcement. We warned other operators who were unknowingly shipping Schedule I narcotics. That ethical leadership during crisis — absorbing revenue loss to protect customers and community — is our character.

October 7, 2022 — The most personal feature. We revealed Colin’s personal marijuana conviction history. “I would love to see people not get hurt for this anymore.” When you understand Colin has faced the same criminal justice consequences many in Russell County have, every other quote carries more weight.

April 21, 2023 — Our most recent feature, where Colin explained: “Right now is actually a pretty Renaissance — a pretty important time that should be enjoyed now.” With Alabama’s medical program still rolling out slowly, that Renaissance applies to Russell County too.

The Science: What Actually Works (and What Doesn’t)

For Russell County residents making healthcare decisions, you need honest science, not hype. Here’s what the evidence actually says about each compound in our formula:

CBD: The Most Studied Cannabinoid

Strongest evidence: Purified CBD has the clearest human evidence for seizure disorders. The FDA-approved Epidiolex is the gold standard [1][2].

Anxiety: A 2024 systematic review covering 316 participants found a statistically significant anxiolytic signal, but authors stressed the clinical sample is limited [3]. It’s promising, not proven for everyone.

Pain: A 2024 review concluded pain literature is promising but heterogeneous, with trial quality limiting confidence [4].

Sleep: A 2023 review found studies methodologically weak, with few objective assessments [5].

Safety: A 2023 meta-analysis found real signals for liver enzyme elevation and possible drug-induced liver injury, especially important for concentrated oral products [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug interactions [1].

Bottom line for Russell County: CBD is the most evidence-developed non-intoxicating cannabinoid, but strong evidence is concentrated in specific indications (seizures) rather than broad wellness claims.

CBG: The Mother Cannabinoid

Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to major cannabinoids, interacting with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7]. Mechanistically interesting, not yet clinically established.

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity — primarily pharmacology-led hypotheses [7][8].

Caution: The 2021 review explicitly notes CBG is already sold commercially while evidence remains thin [7].

Bottom line for Russell County: CBG is a promising minor cannabinoid with limited clinical validation, not proven therapeutic.

Delta-8 THC: The Legal Psychoactive

Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 and delta-9 have broadly similar behavior. Delta-8 is a partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9].

Public health: A 2023 scoping review found evidence dominated by animal studies, chemistry, use reports, and public-health concerns rather than strong human trials. Reports of adverse consequences exist [10].

Manufacturing: Delta-8 interest is tied to greater stability and easier synthesis relative to natural plant levels, creating product-byproduct and lab-testing concerns [11].

Bottom line for Russell County: Delta-8 is psychoactive with real pharmacologic activity but incomplete human safety characterization. Not trivial.

THCa: The Legal Innovation

Evidence profile: Important chemically, but low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor to THC. It doesn’t produce psychoactive effects — IF it stays acidic and isn’t decarboxylated [12].

Research status: In vitro and rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not established human outcomes [12].

Bottom line for Russell County: THCa is a highly relevant precursor whose interpretation depends heavily on route, temperature, processing, and storage. Our product’s legal framework works because THCa converts to THC only when YOU heat it after purchase.

Delta-9 THC: The Controversial Standard

Evidence profile: Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15].

Institutional support: NCCIH identifies relevance for chemotherapy nausea/vomiting, HIV/AIDS appetite/weight loss, some MS and pain outcomes, while stressing many uses remain uncertain [1].

Pain: A 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation [13].

Mental health risk: A 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder, with concerning signals for anxiety/depression in nontherapeutic settings [15].

Safety: Concerns include anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, and vape-related lung injury [1][14][15].

Bottom line for Russell County: Delta-9 THC has legitimate therapeutic relevance but carries clear intoxication, psychiatric, and dose-related safety liabilities. Our formula contains only 90 mg total — dramatically less than traditional RSO’s 600-900 mg per day.

CBN: The Sleep Cannabinoid (Maybe)

Evidence profile: Weak human evidence; marketing ahead of data [12][16][17].

Sleep claims reputation: Widespread, but clinical support is far thinner than market suggests [16][17].

Best review: A 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that substantiate strong sleep-promoting claims [16].

Bottom line for Russell County: CBN is one of the clearest examples where cultural reputation exceeds clinical evidence. Our formula includes 750 mg (25 mg per mL at full dose) because the 2024 sleep literature investigated doses around this level, but we don’t overstate.

CBC: The Emerging Minor Cannabinoid

Evidence profile: Emerging, intriguing, overwhelmingly preclinical [18][19].

Pharmacology: A 2024 review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as interesting research targets [18].

Safety caveat: The 2024 review explicitly notes over-the-counter CBC products are sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line for Russell County: CBC is a scientifically credible minor cannabinoid that deserves more research, not already-validated clinical active.

Terpenes: The Aromatic Dimension

Terpene claims need even stricter interpretation than cannabinoids. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene: Multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — but mostly from nonhuman literature [21]. Oxidation products are contact allergens [22].

Myrcene: Preclinical anxiolytic, antioxidant, anti-inflammatory, analgesic properties, but human studies lacking [23]. Claims of sedation are stronger than current evidence.

Caryophyllene: Selective CB2 receptor agonist — unusual and pharmacologically relevant [24]. Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective discussed, but human confirmation limited [24].

Pinene: Antioxidant, anti-inflammatory, neuroprotective signals justify future study, but well-designed clinical trials lacking [25].

Linalool: Discussed for stress, mood, brain-health pharmacology, but human trials limited [25][26]. Oxidized linalool hydroperoxides are allergens [22].

Humulene: Preclinical evidence for anti-inflammatory and cannabimimetic properties via CB1 and adenosine A2a pathways, but not yet consistent human efficacy [27].

Terpinolene: 2021 systematic review screened 2,449 records, included 57 studies, concluded evidence dominated by in silico, in vitro, and animal studies [28].

Bottom line for Russell County: Terpenes are biologically interesting and contribute to aroma and flavor, but compound-specific therapeutic claims should be conservative.

Our Formula: Complete Open-Source Transparency

We publish everything. If you can’t afford our products, source the ingredients and make your own. That’s the Rick Simpson ethos updated for 2025.

RSO Sublingual Oil Formula

$129.99 — 30mL bottle (553 mg/mL)

• Live terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses: 40-60 per bottle (depending on serving size)
• Dropper: Graduated in 0.1 mL increments for precision

RSO Vape Cartridge Formula

$49.99 — 1 gram cartridge

• Live terpenes: 5%+
• Thread: 510 universal
• Onset: 1-2 minutes
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

Our Terpene Profile

Same for both products:

• Limonene: Citrus-bright, mood
• Myrcene: Relaxation
• Caryophyllene: Pepper/spice, CB2 agonist for inflammation
• Pinene: Forest-fresh, clarity
• Linalool: Floral/lavender, calm
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complexity

How to Use: Condition-Specific Guidance for Russell County

Critical disclaimer: These are informed by research cited throughout this document. They are not medical prescriptions, not FDA-approved, and not a substitute for professional care. Consult a qualified healthcare provider, especially if you have medical conditions, take medications, are pregnant/nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite (For Patients at Russell Medical Center)

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence: Delta-8 THC antiemetic [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5 mL raw sublingual — anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD pain [4], delta-9 THC pain [13], caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

• Before bed: 1.0-2.0 mL sublingual
• 2.0 mL delivers 50 mg CBN — dosage investigated in 2024 sleep literature [16][17]
• 1.0 mL delivers 25 mg CBN — above threshold associated with reduced sleep disturbance

Anxiety and Stress (PTSD, Generalized Anxiety)

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN

Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage effect [20]

General Titration Principle

Start low, go slow. Begin with 0.25-0.5 mL sublingual. Assess effects over 2-3 hours before increasing. Individual responses vary by weight, metabolism, tolerance, medications, and other factors.

Alabama and Russell County: Legal Framework and Access

Farm Bill Compliance

Our products contain less than 0.3% delta-9 THC by dry weight, making them legal under the 2018 Farm Bill and Alabama state law. You do not need a medical card.

Important: Alabama legalized medical cannabis in 2021 (SB46), but the program is still rolling out slowly, with limited qualifying conditions and few operational dispensaries. Many Russell County residents cannot access the state program. Our THCa framework provides a legal alternative: you can purchase hemp-derived products and activate them at home.

Alabama-specific legal notice: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with local laws regarding possession and use of activated products. We ship with full documentation, Certificates of Analysis, and receipts. You accept all legal responsibility.

Delivery to Russell County

We ship nationwide via USPS Priority Mail (2-3 business days), FedEx, and UPS Ground (3-5 business days). All packages are discreet with no cannabis branding visible. Tracking provided.

For Russell County specifically:

• Shipping to Phenix City, Seale, Hurtsboro, Fort Mitchell, Ladonia, and all unincorporated areas
• Typical delivery: 3-5 business days
• Signature-required option available
• Temperature-stable packaging for Alabama summers

We do not currently offer same-day delivery to Russell County (that’s available in Houston’s Texas Medical Center and Inner Loop), but our shipping is fast and reliable.

Why Russell County? Why Now?

Russell County has unique challenges that make our approach especially relevant:

Veteran community: With Fort Benning across the border, Russell County has thousands of veterans dealing with PTSD, chronic pain, and the aftermath of pharmaceutical dependence. Colin’s personal story mirrors yours. He quit Xanax cold turkey using cannabinoids. He uses our vape daily for PTSD. This isn’t theory — it’s survival.

Healthcare access: Russell Medical Center and East Alabama Health provide excellent care, but specialty treatment often requires travel to Birmingham or Atlanta. For chronic conditions where conventional medicine runs out of options, having a legal, tested, multi-cannabinoid product shipped directly to your home matters.

Economic constraints: Russell County’s median household income is below the national average. Our open-source formula philosophy means that if you can’t afford $129.99, you can see exactly what’s in it and source ingredients to make your own. That’s accessibility, not gatekeeping.

Conservative values: We respect that Russell County is culturally conservative. We emphasize legality, safety, evidence, and medical context — not recreational “getting high.” Our raw THCa option provides therapeutic benefits without psychoactive effects for those who need to work, drive, or stay clear-headed.

How to Order

Online: OilWellCBD.com

Phone: (832) 416-2816

Email: [email protected]

Instagram: @oilwellcbd

Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

Final Word: Our Promise to Russell County

We’re not here to sell you snake oil. We’re not here to sell you hope. We’re here because Bentley got up and walked. We’re here because Colin survived PTSD and benzo addiction. We’re here because the science — while incomplete — is promising enough to be worth trying with the best possible version.

If you’re in Russell County dealing with cancer, chronic pain, sleep issues, PTSD, or watching someone you love suffer, you deserve honest answers. You deserve lab-tested products. You deserve to control your own medicine. You deserve to know exactly what’s in the bottle and make your own if you need to.

That’s what we’re offering. Not magic. Not miracles. Just the most thoughtful, transparent, evidence-informed RSO formulation available — legal under Alabama law, shipped to your door, with a founder who has lived the same struggles you have.

Try it. Make your own. Ask us hard questions. We’ll answer directly. That’s the OilWell way.

Legal disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before use. You must be 21 or older to purchase. Buyer assumes responsibility for compliance with local laws. Keep out of reach of children. Do not operate vehicles or machinery while using psychoactive cannabinoids.

References:

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ). NIH/NCI. Updated 2024.

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids. NIH/NCCIH.

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy. Exp Neurol. 2023;359:114238.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders. Psychiatry Res. 2024;339:116049.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals. 2024;17(11):1438.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia. Cannabis Cannabinoid Res. 2023;8(2):213-229.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity. J Intern Med. 2023;293(6):724-752.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review. Molecules. 2024;29(22):5471.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC. Br J Pharmacol. 2022;179(15):3915-3933.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review. Addiction. 2023;118(6):1011-1028.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

12. Moreno-Sanz G. Can You Pass the Acid Test? Cannabis Cannabinoid Res. 2016;1(1):124-130.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain. Ann Intern Med. 2022;175(8):1143-1153.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol and mental health. Ann Intern Med. 2025;178(10):1429-1440.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep. Curr Psychiatry Rep. 2024;26(12):712-727.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene. J Pharmacol Exp Ther. 2024;391(2):206-213.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene. Acta Pharm. 2021;71(3):355-364.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect. Pharmaceuticals. 2024;17(11):1543.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene. J Food Biochem. 2021;45(1):e13566.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, et al. Limonene and linalool hydroperoxides. Contact Dermatitis. 2022;87(1):1-12.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene. Front Nutr. 2021;8:699666.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. Beta-caryophyllene. Biomed Pharmacother. 2021;140:111639.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. Pinene and linalool. Front Psychiatry. 2021;12:583211.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool in depression. Curr Neuropharmacol. 2022;20(6):1073-1092.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. Alpha-humulene. Planta Med. 2024;90(9):664-674.

28. Menezes IO, Scherf JR, Martins AOBPB, et al. Terpinolene. Phytomedicine. 2021;93:153768.

29. Russo EB. Taming THC. Br J Pharmacol. 2011;163(7):1344-1364.